Abstracts and posters

A. G. den Hartog, L. Hirt, E. Hayter, F. L. Moll, A. Halliday, G. J. de Borst, on behalf of the ACST-1 collaborators; Abstract - The risk of occlusion and associated events in the Asymptomatic Carotid Surgery Trial: a 10-year prospective study; 45th Annual Scientific Meeting of the Vascular Society of Great Britain & Ireland, Brighton, UK 2010; Published: Br Jour Surg, 2011;98 (S1): 11-11

A. G. den Hartog, L. Hirt, E. Hayter, F. L. Moll, A. Halliday, G. J. de Borst, on behalf of the ACST-1 collaborators; Abstract - Combined medical therapy and carotid endarterectomy for asymptomatic stenosis: 10-year stroke prevention in ACST-1; 45th Annual Scientific Meeting of the Vascular Society of Great Britain & Ireland, Brighton, UK 2010; Published: Br Jour Surg, 2011; 98 (S1): 9-9

J.Y. Streifler; A. G. den Hartog; S. Pan; D. Thomas; A. Halliday; ACST-1 trial collaborators; Abstract – Importance Of Previous Brain Infarcts In Patients With Asymptomatic Carotid Stenosis And The Impact Of Surgery From The Asymptomatic Carotid Surgery Trial-1, American Heart Association/International Stroke Conference, Hawaii, USA 2013; Published: Stroke, 2013; 44: A67

Halliday A; ACST-2 Collaborators; Poster- What is current best Stroke Prevention Therapy (SPT) for carotid stenosis in patients requiring intervention? Short & longer-term SPT results for 1500 patients in the ACST-2 Trial; 9th UK Stroke Forum Conference, December 2014, Harrogate; Published: Trials 2015;16(suppl):164

A. Huibers, G.J. de Borst, R. Bulbulia, A. Halliday on behalf of ACST-2 collaborative group; Poster - Anti-thrombotic therapy in carotid artery stenting and carotid endarterectomy within the asymptomatic carotid surgery trial-2 (ACST-2); Leading Innovative Vascular Education (LIVE), May 2015, Heraklion, Crete. Prize for best poster presentation

A. Halliday, A Huibers, D Ruvolo on behalf of the ACST-2 Collaborators; Poster- The ACST-2 Trial- Good medical and interventional treatments for patients at high stroke risk; European Stroke Organisation Conference, May 20155, Glasgow, UK

V. Tolva, A. Huibers, R. Casana, R. Bulbulia and A. Halliday on behalf of the ACST-2 Collaborative Group; Poster - Open-cell vs closed-cell stent design: Operators choice and echolucency in the Asymptomatic Carotid Surgery Trial-2 (ACST-2) trial; Annual Meeting European Society for Vascular Surgery, September 2015, Porto, Portugal

A. Huibers, R. Bulbulia, A. Halliday on behalf of ACST collaborative group; Abstract - UK trial patients are at higher stroke risk – a 5000 patient analysis from the ACST trials; Vascular Society, Bournemouth, UK, November 2015

A Halliday, R Bulbulia, L Bonati, R Peto, D de Waard, D Morris, H Pan on behalf of the ACST-2 Collaborative Group; Poster - Asymptomatic Carotid Surgery Trial-2: Stenting vs surgery for tight asymptomatic carotid stenosis. Lower procedural risks and newer techniques. BHF/CRE Oxford Annual Symposium, September 2016, Oxford, UK

A Halliday, R Bulbulia, L Bonati, R Peto, D de Waard, D Morris, H Pan on behalf of the ACST-2 Collaborative Group; Abstract- The Asymptomatic Carotid Surgery Trial-2: Stenting vs surgery for tight asymptomatic carotid stenosis. Changing stenting risks with newer techniques BHF/CRE Oxford Annual Symposium, September 2016, Oxford, UK

ACST-2 Collaborative Group; Abstract - The Asymptomatic Carotid Surgery Trial -2

UK Stroke Forum, November 2016, Liverpool, UK

Bulbulia R, Halliday A, Bonati L, Peto R, Morris D and Pan H.; Abstract - The evolution of carotid intervention: Secular trends in stent type, cerebral protection devices and medication in ACST-2, a large international RCT comparing surgery with stenting European Stroke Journal 2017; 2:18